Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Director | May 07, 2026 | May 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 88,254 |
Reported balance
After 2026-05-09 transaction · row 1
1 source rowRow 1 · 2026-05-09 · Tax withholding · Disposed 882 · Balance 88,254 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 17,700 |
Reported balance
After 2026-05-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-05-07 · Grant · Acquired 17,700 · Balance 17,700 F1: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock.
F2: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SeaSpine Holdings Corp
Report date January 05, 2023 · Filed January 10, 2023
Section 16 reporting ended · disclosed 2023-01-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 1
1 source rowRow 1 · 2023-01-05 · Disposition to issuer · Disposed 88,592 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 36,880 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.68 · Expires 2025-08-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-05 · Disposition to issuer · Disposed 58,559 · Balance 0 F3: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share. F2: The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.18 · Expires 2026-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-01-05 · Disposition to issuer · Disposed 3,858 · Balance 0 F5: This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share. F4: The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.99 · Expires 2026-06-07 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-05 · Disposition to issuer · Disposed 13,920 · Balance 0 F7: This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share. F6: The options vests in equal installments on each of September 7, 2016, December 7, 2016, March 7, 2016 and June 7, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 36,880 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2: The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter.
F3: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share.
F4: The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016.
F5: This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share.
F6: The options vests in equal installments on each of September 7, 2016, December 7, 2016, March 7, 2016 and June 7, 2016.
F7: This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 09, 2026 Filed May 11, 2026 20:40 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 882 | $13.92 | $12,277.44 |
DisclosureSEC source: 0001188650-26-000001 · wk-form4_1778532047.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,254 Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:40 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantRestricted Stock Units · Derivative | 17,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001188650-26-000001 · wk-form4_1778532047.xml · derivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,700 Underlying: Common Stock · 17,700 shares Expires not disclosed F1 · derivative.exercise_price: Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock. F2 · derivative.exercise_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. F2 · derivative.expiration_date: RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 19,592 | $0.00 | $0.00 |
DisclosureSEC source: 0000917520-25-000049 · wk-form4_1747167708.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,136 Read SEC document |
| May 09, 2025 Filed May 13, 2025 20:21 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 392 | $12.25 | $4,802.00 |
DisclosureSEC source: 0000917520-25-000049 · wk-form4_1747167708.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,544 Read SEC document |
| May 12, 2024 Filed May 13, 2024 20:32 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 37 | $25.99 | $961.63 |
DisclosureSEC source: 0001628280-24-022919 · wk-form4_1715632318.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,936 Read SEC document |
| May 12, 2024 Filed May 13, 2024 20:32 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 202 | $25.99 | $5,249.98 |
DisclosureSEC source: 0001628280-24-022919 · wk-form4_1715632318.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,973 Read SEC document |
| May 09, 2024 Filed May 13, 2024 20:32 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 8,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-022919 · wk-form4_1715632318.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,175 Read SEC document |
| May 13, 2023 Filed May 16, 2023 20:34 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 156 | $49.05 | $7,651.80 |
DisclosureSEC source: 0001209191-23-029813 · doc4.xml · nonDerivative · entry 4 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,479 Read SEC document |
| May 13, 2023 Filed May 16, 2023 20:34 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 29 | $49.05 | $1,422.45 |
DisclosureSEC source: 0001209191-23-029813 · doc4.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,635 Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:34 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 816 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029813 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,664 Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:34 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-029813 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,848 Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:19 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerStock Option (right to buy) · Derivative | 13,920 | Not disclosed Strike: $9.99 | Not disclosed |
DisclosureSEC source: 0001637761-23-000040 · wf-form4_167330994244257.xml · derivative · entry 4 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,920 shares Expires 2026-06-07 F7 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 5,794 shares of Orthofix at a price of $24.00 per share. F6 · derivative.exercise_date: The options vests in equal installments on each of September 7, 2016, December 7, 2016, March 7, 2016 and June 7, 2016. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:19 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerStock Option (right to buy) · Derivative | 3,858 | Not disclosed Strike: $17.18 | Not disclosed |
DisclosureSEC source: 0001637761-23-000040 · wf-form4_167330994244257.xml · derivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,858 shares Expires 2026-01-01 F5 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 1,606 shares of Orthofix at a price of $41.27 per share. F4 · derivative.exercise_date: The option vests as to 50% of the underlying shares on February 1, 2016 and as to 25% of the underlying shares on each of May 1, 2016 and August 1, 2016. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:19 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerStock Option (right to buy) · Derivative | 58,559 | Not disclosed Strike: $15.68 | Not disclosed |
DisclosureSEC source: 0001637761-23-000040 · wf-form4_167330994244257.xml · derivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,559 shares Expires 2025-08-01 F3 · price: This option was assumed by Orthofix in the merger and replaced with an option to purchase 24,378 shares of Orthofix at a price of $37.67 per share. F2 · derivative.exercise_date: The option vests as to 25% of the underlying shares on November 1, 2015 and the remaining 75% in three equal quarterly installments thereafter. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:19 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Disposition to issuerCommon Stock | 88,592 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-23-000040 · wf-form4_167330994244257.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 36,880 Orthofix MedicalInc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 319 | $7.77 | $2,478.63 |
DisclosureSEC source: 0001637761-22-000092 · wf-form4_165429135162607.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,592 F2 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on June 2, 2022. No shares were sold in connection with this transaction. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 21:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 15,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-22-000092 · wf-form4_165429135162607.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,911 F1 · shares: The restricted stock award vests in full on June 1, 2023, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting. Read SEC document |
| May 14, 2022 Filed May 17, 2022 20:52 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 131 | $59.32 | $7,770.92 |
DisclosureSEC source: 0001209191-22-029725 · doc4.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,362 Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:52 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 633 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029725 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,493 Read SEC document |
| May 13, 2022 Filed May 17, 2022 20:52 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 3,456 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029725 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,860 Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 22:55 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 37 | $13.25 | $490.25 |
DisclosureSEC source: 0001637761-22-000050 · wf-form4_164643448536774.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,968 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 2, 2022. No shares were sold in connection with this transaction. Read SEC document |
| December 02, 2021 Filed Dec 3, 2021 21:19 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 37 | $13.38 | $495.06 |
DisclosureSEC source: 0001637761-21-000187 · wf-form4_163856636362172.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,005 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on December 2, 2021. No shares were sold in connection with this transaction. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 21:04 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 37 | $16.95 | $627.15 |
DisclosureSEC source: 0001637761-21-000177 · wf-form4_163070303199319.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,042 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on September 2, 2021. No shares were sold in connection with this transaction. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 23:06 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 36 | $20.51 | $738.36 |
DisclosureSEC source: 0001637761-21-000147 · wf-form4_162526718868380.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,079 F2 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on June 30, 2021. No shares were sold in connection with this transaction. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 23:06 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 792 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000147 · wf-form4_162526718868380.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,115 F1 · shares: This restricted stock award was issued to the Reporting Person pursuant to his election under the issuer's director compensation program to receive such award in lieu of a portion of the cash retainer the Reporting Person is entitled to receive in his capacity as a non-employee director of the issuer. The restricted stock award vests immediately on the date of grant. The number of shares was calculated by dividing the portion of the retainer the Reporting Person elected not to receive in cash by the closing price of the issuer's common stock on the last trading day of the quarter. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 20:14 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 382 | $20.28 | $7,746.96 |
DisclosureSEC source: 0001637761-21-000126 · wf-form4_162283766541983.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,323 F3 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on June 3, 2021. No shares were sold in connection with this transaction. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:14 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 3,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000126 · wf-form4_162283766541983.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,705 F2 · shares: The restricted stock award vests as to 25% of the shares subject to the award on the last day of each three-month period of the Reporting Person's continuous service on SeaSpine's board of directors following June 2, 2021. Read SEC document |
| June 02, 2021 Filed Jun 4, 2021 20:14 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 6,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000126 · wf-form4_162283766541983.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,454 F1 · shares: The restricted stock award vests in full on June 2, 2022, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation ("SeaSpine") at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting. Read SEC document |
| May 14, 2021 Filed May 17, 2021 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 2,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033159 · doc4.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,404 Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 48 | $70.65 | $3,391.20 |
DisclosureSEC source: 0001209191-21-033159 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,508 Read SEC document |
| May 13, 2021 Filed May 17, 2021 20:27 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $70.65 | $635.85 |
DisclosureSEC source: 0001209191-21-033159 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,556 Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 23:21 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 42 | $17.40 | $730.80 |
DisclosureSEC source: 0001637761-21-000069 · wf-form4_161731919063820.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,201 F2 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on March 31, 2021. No shares were sold in connection with this transaction. Read SEC document |
| March 31, 2021 Filed Apr 1, 2021 23:21 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 933 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000069 · wf-form4_161731919063820.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,243 F1 · shares: This restricted stock award was issued to the Reporting Person pursuant to his election under the issuer's director compensation program to receive such award in lieu of a portion of the cash retainer the Reporting Person is entitled to receive in his capacity as a non-employee director of the issuer. The restricted stock award vests immediately on the date of grant. The number of shares was calculated by dividing the portion of the retainer the Reporting Person elected not to receive in cash by the closing price of the issuer's common stock on the last trading day of the quarter. Read SEC document |
| February 13, 2021 Filed Feb 16, 2021 21:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 48 | $69.15 | $3,319.20 |
DisclosureSEC source: 0001209191-21-010702 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,565 Read SEC document |
| February 13, 2021 Filed Feb 16, 2021 21:13 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $69.15 | $622.35 |
DisclosureSEC source: 0001209191-21-010702 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,613 Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:07 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 42 | $17.45 | $732.90 |
DisclosureSEC source: 0001637761-21-000007 · wf-form4_160979440857761.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,310 F2 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on December 31, 2020. No shares were sold in connection with this transaction. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:07 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 931 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-21-000007 · wf-form4_160979440857761.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,352 F1 · shares: This restricted stock award was issued to the Reporting Person pursuant to his election under the issuer's director compensation program to receive such award in lieu of a portion of the cash retainer the Reporting Person is entitled to receive in his capacity as a non-employee director of the issuer. The restricted stock award vests immediately on the date of grant. The number of shares was calculated by dividing the portion of the retainer the Reporting Person elected not to receive in cash by the closing price of the issuer's common stock on the last trading day of the quarter. Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:07 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 48 | $56.13 | $2,694.24 |
DisclosureSEC source: 0001209191-20-058454 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,622 Read SEC document |
| November 13, 2020 Filed Nov 16, 2020 21:07 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $56.13 | $505.17 |
DisclosureSEC source: 0001209191-20-058454 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,670 Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:07 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 52 | $14.30 | $743.60 |
DisclosureSEC source: 0001637761-20-000134 · wf-form4_160166922057969.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,421 F2 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on September 30, 2020. No shares were sold in connection with this transaction. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 20:07 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 1,136 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-20-000134 · wf-form4_160166922057969.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,473 F1 · shares: This restricted stock award was issued to the Reporting Person pursuant to his election under the issuer's director compensation program to receive such award in lieu of a portion of the cash retainer the Reporting Person is entitled to receive in his capacity as a non-employee director of the issuer. The restricted stock award vests immediately on the date of grant. The number of shares was calculated by dividing the portion of the retainer the Reporting Person elected not to receive in cash by the closing price of the issuer's common stock on the last trading day of the quarter. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 48 | $51.72 | $2,482.56 |
DisclosureSEC source: 0001209191-20-046777 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,679 Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $51.72 | $465.48 |
DisclosureSEC source: 0001209191-20-046777 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,727 Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 23:40 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 8,488 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-20-000072 · wf-form4_159140044002642.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,337 F1 · shares: The restricted stock award vests in full on June 3, 2021, subject to the Reporting Person not experiencing a termination of service prior to such date. In addition, if the Reporting Person stands for reelection to the board of directors of SeaSpine Holdings Corporation ("SeaSpine") at an annual meeting of stockholders but is not reelected to the board at such annual meeting, the award will vest in full on the date of such annual meeting. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 20:40 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 380 | $10.65 | $4,047.00 |
DisclosureSEC source: 0001637761-20-000053 · wf-form4_159113039236116.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,849 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on May 29, 2020. No shares were sold in connection with this transaction. Read SEC document |
| May 16, 2020 Filed May 20, 2020 20:06 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommkon Stock | 43 | $46.44 | $1,996.92 |
DisclosureSEC source: 0001209191-20-030862 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,736 Read SEC document |
| May 16, 2020 Filed May 20, 2020 20:06 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | Tax withholdingCommon Stock | 9 | $46.44 | $417.96 |
DisclosureSEC source: 0001209191-20-030862 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,779 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 4,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029731 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,788 Read SEC document |
| May 13, 2020 Filed May 15, 2020 20:16 UTC | INTEGRA LIFESCIENCES HOLDINGS CORP IART · Entity 2707 | GrantCommon Stock | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029731 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,570 Read SEC document |
| February 29, 2020 Filed Mar 3, 2020 01:37 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 54 | $14.13 | $763.02 |
DisclosureSEC source: 0001637761-20-000022 · wf-form4_158319942328544.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,229 F1 · shares: Shares withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock that occurred on February 29, 2020. No shares were sold in connection with this transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.